Health Care: Drugs

Cerus Corp (CERS: NASDAQ)

$3.67 n/a | n/a%
08/21/14 - 02:03 PM ET
Company Profile
Price and Volume
Recent Price 3.67
52 Week High 8.00
52 Week Low 3.48
Avg. Daily Vol. (Mil) 0.61
Beta (3 year) 2.34
Share Related Items
Mkt Cap (Mil) 271.76
Shares Out (Mil) 74.05
Float (Mil) 63.08
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 2.50
Current Ratio 3.20
LT Debt/ Equity 0.22
Total Debt / Equity 0.22
Valuation Ratios
Price Earnings n.a.
Price/Sales 7.50
Price/Book 6.15
Price/Cash Flow -8.20
Per Share Data
Earnings -0.48
Sales 0.49
Book Value 0.60
Cash Flow -0.45
Business Summary
Cerus Corp is a biomedical products company, which focuses on commercializing the INTERCEPT Blood System to enhance blood safety.
General Information
2550 Stanwell Drive
Concord, CA 94520
www.cerus.com
Industry : Drugs
Sector: Health Care
Employees: 115
CEO: William M. Greenman
Short Interest
Current Month (Mil) 11.26
Previous Month (Mil) 11.35
Short Interest Ratio (Days) 18.60
Management Effectiveness
Return on Equity n.a.
Return on Assets -44.50
Return on Investments -63.20
Profitability
Gross Margin 44.80
EBIT Margin -92.10
Profit Margin -94.30

Portfolios with CERS

Latest CERS Headlines from TheStreet

More Financial News for CERS

Press Releases for CERS

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter